Regulatory News:
Moberg Pharma AB (STO:MOB)
SUCCESSFUL FOURTH QUARTER AND THE FIRST PROFITABLE FULL YEAR
PERIOD (JAN-DEC 2014)
· Revenue MSEK 200.2 (157.4)
Help employers find you! Check out all the jobs and post your resume.
Regulatory News:
Moberg Pharma AB (STO:MOB)
SUCCESSFUL FOURTH QUARTER AND THE FIRST PROFITABLE FULL YEAR
PERIOD (JAN-DEC 2014)
· Revenue MSEK 200.2 (157.4)
Help employers find you! Check out all the jobs and post your resume.